Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sjögren Syndrome

Tetsuya Kawakita, Shigeto Shimmura, Kazuo Tsubota

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

PURPOSE: The aim of this study is to evaluate the efficacy and safety of oral pilocarpine in treating severe dry eye unresponsive to conventional conservative treatment in patients with Sjögren syndrome.

DESIGN: A prospective study.

METHODS: Oral doses of pilocarpine were administered for at least 3 months to patients with Sjögren syndrome complicated by established dry eye of great severity unresponsive to conventional conservative treatment.

RESULTS: Subjective eye symptoms (dry eye sensation and eye pain), fluorescein staining scores, rose Bengal staining scores, and tear film breakup time measurements improved significantly after 1 month and 3 months of oral treatment with pilocarpine, whereas no significant improvement was noted in Schirmer I testing.

CONCLUSIONS: Oral administration of pilocarpine was useful in treating severe dry eye unresponsive to conventional conservative treatment in patients with Sjögren syndrome from the standpoint of efficacy and safety. Thus, we conclude that oral pilocarpine is effective as a new option in treating severe dry eye.

Original languageEnglish
Pages (from-to)101-105
Number of pages5
JournalAsia-Pacific Journal of Ophthalmology
Volume4
Issue number2
DOIs
Publication statusPublished - 2015 Mar 1

Fingerprint

Pilocarpine
Eye Pain
Staining and Labeling
Safety
Rose Bengal
Fluorescein
Tears
Oral Administration
Prospective Studies
Conservative Treatment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sjögren Syndrome. / Kawakita, Tetsuya; Shimmura, Shigeto; Tsubota, Kazuo.

In: Asia-Pacific Journal of Ophthalmology, Vol. 4, No. 2, 01.03.2015, p. 101-105.

Research output: Contribution to journalArticle

@article{6c13794fd1284424ac57ba8f09944334,
title = "Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sj{\"o}gren Syndrome",
abstract = "PURPOSE: The aim of this study is to evaluate the efficacy and safety of oral pilocarpine in treating severe dry eye unresponsive to conventional conservative treatment in patients with Sj{\"o}gren syndrome.DESIGN: A prospective study.METHODS: Oral doses of pilocarpine were administered for at least 3 months to patients with Sj{\"o}gren syndrome complicated by established dry eye of great severity unresponsive to conventional conservative treatment.RESULTS: Subjective eye symptoms (dry eye sensation and eye pain), fluorescein staining scores, rose Bengal staining scores, and tear film breakup time measurements improved significantly after 1 month and 3 months of oral treatment with pilocarpine, whereas no significant improvement was noted in Schirmer I testing.CONCLUSIONS: Oral administration of pilocarpine was useful in treating severe dry eye unresponsive to conventional conservative treatment in patients with Sj{\"o}gren syndrome from the standpoint of efficacy and safety. Thus, we conclude that oral pilocarpine is effective as a new option in treating severe dry eye.",
author = "Tetsuya Kawakita and Shigeto Shimmura and Kazuo Tsubota",
year = "2015",
month = "3",
day = "1",
doi = "10.1097/APO.0000000000000040",
language = "English",
volume = "4",
pages = "101--105",
journal = "Asia-Pacific Journal of Ophthalmology",
issn = "2162-0989",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sjögren Syndrome

AU - Kawakita, Tetsuya

AU - Shimmura, Shigeto

AU - Tsubota, Kazuo

PY - 2015/3/1

Y1 - 2015/3/1

N2 - PURPOSE: The aim of this study is to evaluate the efficacy and safety of oral pilocarpine in treating severe dry eye unresponsive to conventional conservative treatment in patients with Sjögren syndrome.DESIGN: A prospective study.METHODS: Oral doses of pilocarpine were administered for at least 3 months to patients with Sjögren syndrome complicated by established dry eye of great severity unresponsive to conventional conservative treatment.RESULTS: Subjective eye symptoms (dry eye sensation and eye pain), fluorescein staining scores, rose Bengal staining scores, and tear film breakup time measurements improved significantly after 1 month and 3 months of oral treatment with pilocarpine, whereas no significant improvement was noted in Schirmer I testing.CONCLUSIONS: Oral administration of pilocarpine was useful in treating severe dry eye unresponsive to conventional conservative treatment in patients with Sjögren syndrome from the standpoint of efficacy and safety. Thus, we conclude that oral pilocarpine is effective as a new option in treating severe dry eye.

AB - PURPOSE: The aim of this study is to evaluate the efficacy and safety of oral pilocarpine in treating severe dry eye unresponsive to conventional conservative treatment in patients with Sjögren syndrome.DESIGN: A prospective study.METHODS: Oral doses of pilocarpine were administered for at least 3 months to patients with Sjögren syndrome complicated by established dry eye of great severity unresponsive to conventional conservative treatment.RESULTS: Subjective eye symptoms (dry eye sensation and eye pain), fluorescein staining scores, rose Bengal staining scores, and tear film breakup time measurements improved significantly after 1 month and 3 months of oral treatment with pilocarpine, whereas no significant improvement was noted in Schirmer I testing.CONCLUSIONS: Oral administration of pilocarpine was useful in treating severe dry eye unresponsive to conventional conservative treatment in patients with Sjögren syndrome from the standpoint of efficacy and safety. Thus, we conclude that oral pilocarpine is effective as a new option in treating severe dry eye.

UR - http://www.scopus.com/inward/record.url?scp=84991248742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991248742&partnerID=8YFLogxK

U2 - 10.1097/APO.0000000000000040

DO - 10.1097/APO.0000000000000040

M3 - Article

C2 - 26065354

AN - SCOPUS:84991248742

VL - 4

SP - 101

EP - 105

JO - Asia-Pacific Journal of Ophthalmology

JF - Asia-Pacific Journal of Ophthalmology

SN - 2162-0989

IS - 2

ER -